Filters byReset all
Conference Search Results
Search Criteria : Neurosurgery ×
7th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders
Nov 21, 2020 | CME : 6.75 | Hours : 6.75
7th Annual Advances in Neurology: Diagnosis and Practical Management of Patients with Nervous System Disorders is organized by Icahn School of Medicine at Mount Sinai (ISMMS) and will be held on Nov 21, 2020. Accreditation: The Icahn School of Medicine at Mount Sinai designates thislive activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity / AMA PRA Category 1 Credits™ (6.75 hours), Non-Physician Attendance (6.75 hours) Course Overview: The 7th Annual Advances in Neurology is a full-day virtual CME event that will provide clinicians with an update on diagnostic processes, cutting-edge technologies, and innovative management strategies in these 8 areas of neurology: headache, movement disorders and deep brain stimulation, epilepsy, neurological manifestations of COVID-19, stroke, multiple sclerosis, neuromuscular disease, physician-patient communication. Through didactic lecture, case presentations, and interactive discussions with expert clinicians, attendees will be better enabled to diagnose and manage patients living with neurologic disorders in 2020 and beyond. Patient simulators will interact with faculty to provide an enhanced learning experience for participants. Objectives: • Discuss existing, new, and potential options for migraine treatment and prevention including oral medications, devices, injectables, and interventional therapies. • Explain the updated guidelines and criteria for diagnosing and categorizing multiple sclerosis and describe a comprehensive management plan. • Identify appropriate treatment approaches for acute ischemic stroke and recognize cases that are appropriate for referral to comprehensive stroke centers offering acute endovascular interventions. • Discuss the neurological manifestations of COVID-19. • Explain the value of electrodiagnostic testing (nerve conduction studies, electromyography, and neuromuscular ultrasound) in securing a neuromuscular disease diagnosis. • Describe surgical options for the treatment of epilepsy and distinguish an ideal candidate. • Identify a movement disorder patient who is a candidate for deep brain stimulation (DBS) surgery. • Explain how autonomic function testing improves recognition and diagnosis of chronic pain syndromes, and more broadly, neurological illnesses. • Outline the elements of a communication plan for delivering bad news to a patient with neurological disease.
Jun 15, 2016 - Jan 15, 2022 | CME : 35.75 | USD $1,095.00
Neurosurgery - A Comprehensive Review is organized by Ebix | Oakstone Publishing, LLC. Release Date: Jan 15, 2019 Expiration Date: Jan 15, 2022 Accreditation: This CME Conference has been approved for a maximum of 35.75 AMA PRA Category 1 Credits ™. Overview: Neurosurgery – A Comprehensive Review covers a wide set of topics and provides you with the most relevant information on core concepts. Led by Ian F. Dunn, MD, FAANS, it sheds light on the latest trends and best practices to provide enhanced care to patients. It will help you to better: • Evaluate and apply the latest neurosurgical treatments • Outline the best practices in management of vascular disorders • Define the latest techniques in functional neurosurgery • Apply best surgical techniques for the spine, brain and spinal tumors, and nerve injury Learning Objectives: Upon completion of this activity, the participant will be able to: • Evaluate the most current neurosurgical techniques available in order to treat patients with neurosurgical problems • Analyze recent literature and data regarding clinical trials relevant to the practice of neurosurgery • Describe best practices in the management of patients requiring surgery for vascular disorders • Explain the latest techniques used in functional neurosurgery • Differentiate among the techniques used for spine surgery • Discuss the most appropriate procedures for the management of brain tumors and spinal tumors • Identify the most optimal methods for nerve injury and tumors • Assess the best neurosurgical treatment plans for pituitary disorders Additional details will be posted as soon as they are available.
Nov 29, 2016 - Nov 29, 2022 | CME : 1.5 | USD $125.00
Endoscopic Series 2 of 7: Pituitary Tumors and CSF Leaks is organized by Congress of Neurological Surgeons (CNS). Original Release Date: 11/29/2016 Termination Date: 11/29/2022 Accreditation: The Congress of Neurological Surgeons designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Learning Objectives: Upon completion of this educational activity, participants will be able to: • Describe anatomy of Sellar/Parasellar region • Discuss endoscopic endonasal pituitary surgery • Comprehension of transitioning from the Microscope • Identify cavernous sinus invasion • Explain reconstruction of sella • Comprehend special considerations in endonasal endoscopic repair of spontaneous CSF leak Claiming Credit: • Each section of the package needs to be completed in order • To move to the next section please click Continue, then click on the title of the next item on the left navigation • Once all sections are complete (marked by a green light), you can exit out of the product • Click on MYLEARNING then click the Completed tab • Under the Credit(s) column please click Claim and enter the number of credits you are claiming • Click on Certificate under the product name to print your certificate Additional details will be posted as soon as information is available.
Jan 11, 2018 - Jan 10, 2021 | CME : 1 | USD $105.00
Pediatric Brain Tumors-2017 is organized by American Society for Radiation Oncology (ASTRO) and will be held from Jan 11, 2018 - Jan 10, 2021. The target audience for this medical event is radiation oncologists, surgeons, physicists, and radiation oncology residents. This CME Conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits. Course Description: In this new version of the well-received Pediatric Brain Tumor Refresher course, the speakers will cover current recommendations for the management of ependymoma, non germinomatous germ cell tumors and medulloblastoma. They will review appropriate contouring of tumor volumes, normal structures and dose constraints. They will discuss the recent trials in these tumors and the resulting changes in management. Learning Objectives: After this session, attendees should be able to: • Identify and contour CNS normal structures. • Apply the standard-of-care and latest updates in RT delivery for pediatrics CNS cancers. • Identify the most recent molecular findings in pediatrics CNS cancer. Additional details will be posted as soon as they are available.
Mar 20, 2018 - Mar 19, 2021 | CME : 1 | USD $35.00
Cerebral Microbleeds: Imaging and Clinical Significance is organized by Radiological Society of North America (RSNA) and will be held during Mar 20, 2018 - Mar 19, 2021. This CME Conference has been approved for a maximum of 1.0 AMA PRA Category 1 Credits. Conference Description : The goal of the Radiology articles designated for self-assessment CME and their accompanying tests is to increase understanding of the radiologic characteristics of a variety of pathologic conditions and physics principles. Conference Objectives : • Describe how technical MR parameters and sequence protocols may influence the detection of cerebral microbleeds (CMBs). • Discuss limitations of the detection of CMBs in MR imaging and how to distinguish CMBs from microbleed mimics. • Discuss the role of increasing microbleed accumulation during aging and cognitive decline. • Explain how the spatial distribution of CMBs may contribute to differential diagnosis. Additional details will be posted as soon as they are available.
Neurology: Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury
Apr 24, 2018 - Apr 24, 2021 | CME : 0.75
Neurology: Dorsal and ventral horn atrophy is associated with clinical outcome after spinal cord injury is organized by American Academy of Neurology (AAN) and will be held from Apr 24, 2018 - Apr 24, 2021. The target audience for this medical event is physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits. Learning Objectives: Upon completion of the article by Huber et al, the participant should be able to: • Describe differences in atrophy of white matter versus gray matter regions in this cohort of patients with chronic spinal cord injury (SCI) • Discuss the association between higher levels of ventral horn area and various clinical and neurophysiologic outcomes following SCI in this study • Describe the association between SCI lesion severity (area, length) and the presence of neurodegeneration at levels remote from the site of injury in this study Additional details will be posted as soon as they are available.
Nov 21, 2020 | CME : 3.5 | Hours : 3.5
Latest Updates on Neuroimmunology: 5th Annual Conference for Healthcare Professionals and Patients is organized by Cedars-Sinai Medical Center and will be held on Nov 21, 2020. Accreditation: Credit Designation Statement: Cedars-Sinai Medical Center designates this Live Activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credits: AMA PRA Category 1 Credit(s)™ (MD, DO) (3.50 hours), Non-Physician Attendance (RN, NP, PA and Others) (3.50 hours) Overview: This one-day program will present content on adult and pediatric neuroimmune disorders, such as multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD). Led by expert faculty, you will learn about these rare and challenging disorders and the importance of a careful diagnosis and early intervention using the latest medical approaches. Morning and afternoon panels will provide ample time for clarification of clinical points and encourage interactivity between participants and presenters. Objectives: • Describe the new diagnostic criteria for multiple sclerosis (MS) and neuromyelitis optica spectrum disorders (NMOSD) • Summarize the clinical presentation and differential diagnoses of demyelinating disorders including NMOSD and MS • Recognize the potential severity of relapses and other unique issues to address with NMOSD and MS patients who are pregnant or considering pregnancy • Consider race and ethnicity for patients presenting with neuroimmunological disorders and describe the implications for individualized care • Describe recent visual outcomes in MS and NMOSD and the implications for the care of patients with demyelinating disorders
Dec 04, 2020 | CME : 7.75
New York Neurosurgery Update: A One Day Symposium is organized by NYU Grossman School of Medicine. This online CME course will be held on Dec 04, 2020. How many CME/CE credits can be earned by attending New York Neurosurgery Update: A One Day Symposium online CME course? Accreditation: The NYU Grossman School of Medicine assigns this online CME activity for a maximum of 7.75 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit equivalent with the extent of their participation in the activity. What is the significance of the New York Neurosurgery Update: A One Day Symposium online CME course? Course Description: The spectrum of neurosurgery encompasses cranial, spinal, and peripheral nerve disorders related to vascular disease, brain tumors, pain, movement and behavioral disorders, epilepsy, and trauma. Clinical challenges in both adults and children are governed by neurosurgeons together with partners in neurology, oncology, radiation oncology, otolaryngology, radiology, pathology, orthopedic surgery, rehabilitation medicine, and neuroscience. This virtual one-day course will discuss important clinical problems for which there may be clinical equipoise on available options, or for which prevailing science does not provide solutions based on high-level medical evidence. What are the objectives of the New York Neurosurgery Update: A One Day Symposium online CME course? Course Objectives: At the conclusion of this online CME activity, clinicians should be able to: • Assess the purposes of resection, radiosurgery, laser ablation, and drug-based strategies for different brain tumors and make appropriate treatment decisions for their patients • Examine the roles and develop treatment algorithms involving surgical intervention, diagnostic anesthetic blocks, neuromodulation, spinal instrumentation, and fixation for degenerative and oncologic diseases of the spine • Determine the roles for surgical resection, laser ablation, medical management, and neuromodulation in the management of the epileptic disorder • Picture how primary and adjuvant radiosurgery can be used to control tumors and other brain disorders and avoid new neurological deficits • Explain how patient selection and medical evidence helps decision-making for neurovascular disorders • Outline treatment opportunities for hydrocephalus, depending on the etiology and patient age • Elaborate decision-making algorithms for diagnosis and management of brain trauma and elevated intracranial pressure • Review advances in telemedicine that can be employed to assess patients, especially during the pandemic
Dec 04, 2020 | CME : 4.75
32nd Annual Pan Philadelphia Neurosurgery Conference - Virtual Meeting is organized by Thomas Jefferson University (TJU) and will be held on Dec 04, 2020. Accreditation: Designation of Credit: Physicians: This educational activity is designated for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Healthcare Professionals: This educational activity is designated for 4.75 AMA PRA Category 1 Credits™. Participants should claim only the credit commensurate with the extent of their participation in the activity. Course Description: Co-directed by three area Neurosurgical Training Programs: the Sidney Kimmel Medical College at Thomas Jefferson University, Lewis Katz School of Medicine at Temple University, and the Perelman School of Medicine at University of Pennsylvania, this year’s symposium will be devoted to the following theme - Neurosurgery Frontiers: Adapting and Advancing Into the Future. Four keynote addresses by Zoher Ghogawala, MD, Steven N. Kalkanis, MD, Michael T. Lawton, MD, and Andre Machado, MD, PhD will carry forward the theme by discussing past challenges and current controversies of spine, tumor, vascular and functional neurosurgery. Panel discussions on the futures of these four areas will be explored. Each panel will examine how advances in these disciplines can significantly impact neurosurgical practice. Additionally, a resident research competition will provide an analytical review of current research endeavors. Course Objectives: At the conclusion of this course, participants should be able to: • Summarize the recent breakthroughs in cerebrovascular neurosurgery and the applications, implications, and outcomes associated with these new techniques. • Analyze the role of deep brain stimulation on stroke rehabilitation and recovery. • Distinguish the current controversies and future directions in spinal surgery, neuro-oncology, neurovascular surgery, and functional neurosurgery and examine the challenges associated in each area. • Examine the innovations in precision based tumor surgery and how they can be applied into practice. • Discuss the current clinical trials on spine surgery and their potential implications for patients. • Apply course discussion outcomes and strategies to individual practice as part of a continuing improvement process.
The Cutting Edges in Stroke and Neurology Update 2020: Case by Case (In Honor of Dr. Albert Goodgold)
Dec 17 - 18, 2020 | CME : 15.5 | Contact Hours : 8
The Cutting Edges in Stroke and Neurology Update 2020: Case by Case (In Honor of Dr. Albert Goodgold) is organized by NYU Grossman School of Medicine and will be held from Dec 17 - 18, 2020. Accreditation: Credit Designation Statement: Stroke: The NYU School of Medicine designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Neurology: The NYU School of Medicine designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Continuing Nursing Education Contact Hours: Stroke: This program will award 8.0 continuing nursing education contact hours. Participants must complete a course evaluation to claim contact hours for this learning activity. The NYU Meyers College of Nursing Center for Continuing Education in Nursing is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation. Description: Stroke: This course will provide a comprehensive update on ischemic stroke prevention and the evaluation and management of acute ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage, along with other cerebrovascular conditions. Both established and emerging management strategies will be addressed by expert lecturers and discussants for this course. Discussion time will allow attendees to have their questions answered. In addition, several debate sessions will highlight current controversies in the field. Neurology: This comprehensive, one-day course will provide a focused, complete, and advanced update for clinical neurology across subspecialties. Using a clinical case or video-based format, both established and emerging therapies and diagnostic approaches will be addressed by the expert lectures and panelists/discussants in this course. It will also augment learning by providing visual teaching materials. Evaluation of common as well as more rare disorders in neurology will be covered by the diverse and knowledgeable course faculty from the rapidly growing NYU Grossman School of Medicine Department of Neurology. Educational Objectives: Stroke: After participating in this activity, clinicians should be able to: • Identify patients who might benefit from intravenous tPA outside of the usual time windows and conditions • Properly recognize pitfalls in the interpretation of perfusion imaging that could otherwise lead to erroneous decision making • Identify patients with central retinal artery occlusion who might benefit from thrombolytics or endovascular therapies • Recognize and manage acute cerebrovascular disorders in patients infected with COVID-19 • Recognize racial and ethnic disparities in stroke care and describe possible methodologies to reduce them and mitigate their effects on patient care • Properly evaluate and manage patients with stroke due to infectious or neoplastic etiologies • Appropriately evaluate and manage patients with unruptured cerebral aneurysms as well as those with aneurysmal subarachnoid hemorrhage • Appropriately institute stroke prevention strategies in patients with various ischemic stroke subtypes • Describe and weigh the risks and benefits of restarting anticoagulation after intraparenchymal hemorrhage • Appropriately prognosticate the likelihood for motor and/or language recovery after ischemic stroke and discuss a novel option to help improve motor recovery after stroke Neurology: After participating in this activity, clinicians should be able to: • Identify neurologic problems and determine which patients to treat or refer to other health care professional for additional treatments • Obtain an appropriate history and perform a physical exam to diagnose different and complex neurologic diseases • Consult with their colleagues in other subspecialties in order to determine the appropriate course of treatment for the patient • Develop strategies to incorporate technology in the diagnosis and treatment of patients with epilepsy.